ABCA3 p.Arg295Cys

[switch to full view]
Comments [show]
Publications
PMID: 19861431 [PubMed] Park SK et al: "Identification and characterization of a novel ABCA3 mutation."
No. Sentence Comment
11 A novel heterozygous mutation that results in the substitution of cysteine for arginine at amino acid 295 in ABCA3 was identified in a premature infant with chronic respiratory insufficiency and abnormal lamellar bodies.
X
ABCA3 p.Arg295Cys 19861431:11:66
status: NEW
Login to comment

15 The ABCA3 protein containing the R295C mutation undergoes normal glycosylation and intracellular localization but has dramatically reduced ATP hydrolysis activity (12% of wild type).
X
ABCA3 p.Arg295Cys 19861431:15:33
status: NEW
Login to comment

31 This mutation substitutes a cysteine for an arginine at amino acid position 295 in the first intracellular loop (ICL-1) of ABCA3.
X
ABCA3 p.Arg295Cys 19861431:31:28
status: NEW
Login to comment

32 Functional analysis of this R295C mutation demonstrates that the mutation severely compromises the ability of the protein to hydrolyze ATP.
X
ABCA3 p.Arg295Cys 19861431:32:28
status: NEW
Login to comment

49 The R295C mutant was initially generated from the pEGFPN1-ABCA3-green fluorescent protein (GFP) construct (14) with the QuikChange II XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the following primers: forward 5=-AGGCTGAAG- GAGTACATGTGCATGATGGGGCTCAGCAG-3= and reverse 5=-CTGCTGAGCCCCATCATGCACATGTACTCCTTCAGCCT-3= (underlines indicate substituted nucleotides).
X
ABCA3 p.Arg295Cys 19861431:49:4
status: NEW
Login to comment

50 A R295C-GFP construct in a pCAGIpuro vector was generated by inserting the coding region of ABCA3-R295C-GFP into the pCAGIpuro vector.
X
ABCA3 p.Arg295Cys 19861431:50:2
status: NEW
X
ABCA3 p.Arg295Cys 19861431:50:98
status: NEW
Login to comment

51 Presence of the mutation in the pEGFN1-ABCA3-R295C-GFP and pCAGIpuro-ABCA3-R295C-GFP constructs was confirmed by sequencing.
X
ABCA3 p.Arg295Cys 19861431:51:45
status: NEW
X
ABCA3 p.Arg295Cys 19861431:51:75
status: NEW
Login to comment

53 Transient transfections of HEK293 cells with wild-type ABCA3-GFP and ABCA3 mutants L101P-GFP, N568D-GFP, and L982P-GFP (14), as well as the new pEGFPN1 construct for R295C-GFP, were performed with FuGENE 6 transfection reagent (Roche Applied Science, Indianapolis, IN) as previously described (14).
X
ABCA3 p.Arg295Cys 19861431:53:166
status: NEW
Login to comment

63 RESULTS Identification of a novel R295C mutation.
X
ABCA3 p.Arg295Cys 19861431:63:34
status: NEW
Login to comment

80 Although the R295C variant had not been observed in previously characterized populations, it was unclear whether the R295C variant was a common polymorphism in Hmong individuals or a clinically significant mutation.
X
ABCA3 p.Arg295Cys 19861431:80:13
status: NEW
X
ABCA3 p.Arg295Cys 19861431:80:117
status: NEW
Login to comment

81 To determine whether the R295C variant was a polymorphism or a mutation, the frequency of this variant in the Hmong population was examined.
X
ABCA3 p.Arg295Cys 19861431:81:17
status: NEW
X
ABCA3 p.Arg295Cys 19861431:81:25
status: NEW
Login to comment

84 None of these individuals had the R295C variant, indicating that this variation is indeed a mutation and not a polymorphism.
X
ABCA3 p.Arg295Cys 19861431:84:34
status: NEW
Login to comment

86 Effects of ABCA3 R295C mutation on function.
X
ABCA3 p.Arg295Cys 19861431:86:17
status: NEW
X
ABCA3 p.Arg295Cys 19861431:86:64
status: NEW
Login to comment

87 The R295C mutation is located in the first ICL (ICL-1) of the protein (Fig. 2A) and is adjacent to the previously reported mutant E292V (2).
X
ABCA3 p.Arg295Cys 19861431:87:4
status: NEW
Login to comment

88 The R295C mutation resides in a region that is conserved in different members of the ABCA subfamily (Fig. 2B) and across ABCA3 homologs in vertebrates (Fig. 2C).
X
ABCA3 p.Arg295Cys 19861431:88:4
status: NEW
Login to comment

90 To examine whether the intracellular localization of the R295C mutant was altered, the glycosylation state of the R295C mutant was characterized.
X
ABCA3 p.Arg295Cys 19861431:90:57
status: NEW
X
ABCA3 p.Arg295Cys 19861431:90:114
status: NEW
Login to comment

91 Membranes from HEK293 cells expressing wild-type ABCA3-GFP, the R295C-GFP mutant, or several previously characterized mutants were examined for sensitivity to the glycosidases Endo H and PNGase F.
X
ABCA3 p.Arg295Cys 19861431:91:64
status: NEW
Login to comment

95 Schematic diagram of ATP-binding cassette protein A3 (ABCA3) and conservation of amino acids in the region of the R295C mutant.
X
ABCA3 p.Arg295Cys 19861431:95:42
status: NEW
X
ABCA3 p.Arg295Cys 19861431:95:114
status: NEW
Login to comment

97 ଁ, Mutations reported previously; ૽, novel mutant R295C.
X
ABCA3 p.Arg295Cys 19861431:97:62
status: NEW
Login to comment

99 Type I mutations include L101P, L982P, L1553P, and Q1591P; type II mutations include E292V, N568D, E690K, T1114, G1221S, and L1580P (13, 14).
X
ABCA3 p.Arg295Cys 19861431:99:4
status: NEW
Login to comment

100 B: alignment of sequences surrounding the R295C mutation in ICL-1 in various members of the ABCA subfamily.
X
ABCA3 p.Arg295Cys 19861431:100:42
status: NEW
Login to comment

101 C: alignment of sequences surrounding the R295C mutation in human, rat, mouse, and chimpanzee.
X
ABCA3 p.Arg295Cys 19861431:101:42
status: NEW
Login to comment

104 The R295C variant demonstrated a level of resistance to Endo H comparable to that of the wild-type protein (Fig. 3A, compare lanes 6 and 7 to lanes 2 and 3), suggesting that the variant protein has undergone normal glycosylation and resides in post-Golgi membranes.
X
ABCA3 p.Arg295Cys 19861431:104:4
status: NEW
X
ABCA3 p.Arg295Cys 19861431:104:78
status: NEW
Login to comment

105 As reported previously, the N568D variant shows resistance to Endo H (Fig. 3A, lanes 8 and 9) at a level similar to that of the wild-type protein; however, the L101P and L982P variants (Fig. 3A, lanes 4 and 5 and lanes 10 and 11, respectively) show no Endo H resistance, indicating that these mutants have not left the endoplasmic reticulum (14).
X
ABCA3 p.Arg295Cys 19861431:105:23
status: NEW
Login to comment

107 To determine whether the R295C mutation affected the ATP hydrolysis activity of the R295C mutant, vanadate-induced nucleotide trapping with photoaffinity labeling of the trapped intermediate (3) was examined.
X
ABCA3 p.Arg295Cys 19861431:107:25
status: NEW
X
ABCA3 p.Arg295Cys 19861431:107:84
status: NEW
X
ABCA3 p.Arg295Cys 19861431:107:94
status: NEW
Login to comment

109 As shown in Fig. 4A, the level of vanadate-induced nucleotide trapping in the R295C mutant was greatly reduced compared with that of the wild-type ABCA3 protein.
X
ABCA3 p.Arg295Cys 19861431:109:55
status: NEW
X
ABCA3 p.Arg295Cys 19861431:109:78
status: NEW
Login to comment

110 The level of the ABCA3-R295C-GFP mutant protein was comparable to that of wild-type ABCA3-GFP as demonstrated in the anti-GFP immunoblot.
X
ABCA3 p.Arg295Cys 19861431:110:23
status: NEW
Login to comment

111 Vanadate-induced nucleotide trapping was also decreased in the N568D mutant as reported previously (14).
X
ABCA3 p.Arg295Cys 19861431:111:63
status: NEW
Login to comment

112 Quantitation of three independent experiments demonstrated that the degree of trapping in the R295C mutant was dramatically reduced to 12% of that of the wild type (Fig. 4B).
X
ABCA3 p.Arg295Cys 19861431:112:94
status: NEW
Login to comment

113 These results indicate that the ability of the R295C mutant to hydrolyze ATP is severely impaired.
X
ABCA3 p.Arg295Cys 19861431:113:47
status: NEW
Login to comment

114 DISCUSSION The results presented here demonstrate that R295C is a novel mutation that results in severely impaired ATP hydrolysis activity as indicated by the dramatic reduction in vanadate-induced nucleotide trapping.
X
ABCA3 p.Arg295Cys 19861431:114:55
status: NEW
X
ABCA3 p.Arg295Cys 19861431:114:191
status: NEW
Login to comment

116 The E292V mutation is in ICL-1 only three amino acids from the R295C mutation.
X
ABCA3 p.Arg295Cys 19861431:116:63
status: NEW
Login to comment

119 A: 20 ␮g of membrane fraction from untransfected HEK293 cells (lanes 1 and 2), HEK293 cells stably expressing WT ABCA3-GFP (lanes 3 and 4), ABCA3-GFP mutants N568D (lanes 5 and 6), and R295C (lanes 7 and 8) were incubated with 20 ␮M 8-azido-[␣-32 P]ATP in the absence (-) or presence (ϩ) of 0.4 mM orthovanadate (Vi) and 3 mM MgCl2 as described under MATERIALS AND METHODS.
X
ABCA3 p.Arg295Cys 19861431:119:192
status: NEW
Login to comment

126 A: 20 ␮g of membrane fraction from HEK293 cells transiently transfected with WT ABCA3-GFP (lanes 2 and 3) or with ABCA3-GFP mutants L101P (lanes 4 and 5), R295C (lanes 6 and 7), N568D (lanes 8 and 9), and L982P (lanes 10 and 11) were treated without (-) or with (ϩ) endoglycosidase H (Endo H) and analyzed by 5% SDS-PAGE followed by immunoblotting with anti-GFP antibody. Lane 1, immunoblotting of untransfected HEK293 cells.
X
ABCA3 p.Arg295Cys 19861431:126:162
status: NEW
Login to comment

127 B: WT ABCA3-GFP (lanes 2 and 3) or ABCA3-GFP mutants L101P (lanes 4 and 5), R295C (lanes 6 and 7), N568D (lanes 8 and 9), and L982P (lanes 10 and 11) were treated without (-) or with (ϩ) peptide N-glycosidase F (PNGase F) and were then analyzed by 5% SDS-PAGE followed by immunoblotting with anti-GFP antibody. Lane 1, immunoblotting of untransfected HEK293 cells.
X
ABCA3 p.Arg295Cys 19861431:127:4
status: NEW
X
ABCA3 p.Arg295Cys 19861431:127:76
status: NEW
Login to comment

131 The R295C mutation does not affect glycosylation and intracellular localization of the protein.
X
ABCA3 p.Arg295Cys 19861431:131:4
status: NEW
X
ABCA3 p.Arg295Cys 19861431:131:50
status: NEW
Login to comment

134 Normal glycosylation and intracellular localization of the R295C mutant is indicated by the similar levels of sensitivity to Endo H and PNGase F observed for the wild-type ABCA3-GFP protein and the R295C mutant.
X
ABCA3 p.Arg295Cys 19861431:134:59
status: NEW
X
ABCA3 p.Arg295Cys 19861431:134:198
status: NEW
Login to comment

135 The observation that a substantial portion of the R295C mutant protein is resistant to Endo H indicates that the mutation does not affect intracellular localization.
X
ABCA3 p.Arg295Cys 19861431:135:50
status: NEW
Login to comment

144 One possibility is that an interaction between the R295C mutation and the patient`s prematurity resulted in the severe BPD observed.
X
ABCA3 p.Arg295Cys 19861431:144:51
status: NEW
Login to comment

147 In conclusion, clinical management of a premature infant with severe BPD and chronic respiratory failure led to the discovery of the novel ABCA3 mutation R295C.
X
ABCA3 p.Arg295Cys 19861431:147:154
status: NEW
Login to comment

5 A novel heterozygous mutation that results in the substitution of cysteine for arginine at amino acid 295 in ABCA3 was identified in a premature infant with chronic respiratory insufficiency and abnormal lamellar bodies.
X
ABCA3 p.Arg295Cys 19861431:5:66
status: NEW
Login to comment

9 The ABCA3 protein containing the R295C mutation undergoes normal glycosylation and intracellular localization but has dramatically reduced ATP hydrolysis activity (12% of wild type).
X
ABCA3 p.Arg295Cys 19861431:9:33
status: NEW
Login to comment

25 This mutation substitutes a cysteine for an arginine at amino acid position 295 in the first intracellular loop (ICL-1) of ABCA3.
X
ABCA3 p.Arg295Cys 19861431:25:28
status: NEW
Login to comment

26 Functional analysis of this R295C mutation demonstrates that the mutation severely compromises the ability of the protein to hydrolyze ATP.
X
ABCA3 p.Arg295Cys 19861431:26:28
status: NEW
Login to comment

44 The R295C mutant was initially generated from the pEGFPN1-ABCA3-green fluorescent protein (GFP) construct (14) with the QuikChange II XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the following primers: forward 5=-AGGCTGAAG- GAGTACATGTGCATGATGGGGCTCAGCAG-3= and reverse 5=-CTGCTGAGCCCCATCATGCACATGTACTCCTTCAGCCT-3= (underlines indicate substituted nucleotides).
X
ABCA3 p.Arg295Cys 19861431:44:4
status: NEW
Login to comment

45 A R295C-GFP construct in a pCAGIpuro vector was generated by inserting the coding region of ABCA3-R295C-GFP into the pCAGIpuro vector.
X
ABCA3 p.Arg295Cys 19861431:45:2
status: NEW
X
ABCA3 p.Arg295Cys 19861431:45:98
status: NEW
Login to comment

46 Presence of the mutation in the pEGFN1-ABCA3-R295C-GFP and pCAGIpuro-ABCA3-R295C-GFP constructs was confirmed by sequencing.
X
ABCA3 p.Arg295Cys 19861431:46:45
status: NEW
X
ABCA3 p.Arg295Cys 19861431:46:75
status: NEW
Login to comment

48 Transient transfections of HEK293 cells with wild-type ABCA3-GFP and ABCA3 mutants L101P-GFP, N568D-GFP, and L982P-GFP (14), as well as the new pEGFPN1 construct for R295C-GFP, were performed with FuGENE 6 transfection reagent (Roche Applied Science, Indianapolis, IN) as previously described (14).
X
ABCA3 p.Arg295Cys 19861431:48:166
status: NEW
Login to comment

58 RESULTS Identification of a novel R295C mutation.
X
ABCA3 p.Arg295Cys 19861431:58:34
status: NEW
Login to comment

75 Although the R295C variant had not been observed in previously characterized populations, it was unclear whether the R295C variant was a common polymorphism in Hmong individuals or a clinically significant mutation.
X
ABCA3 p.Arg295Cys 19861431:75:13
status: NEW
X
ABCA3 p.Arg295Cys 19861431:75:117
status: NEW
Login to comment

76 To determine whether the R295C variant was a polymorphism or a mutation, the frequency of this variant in the Hmong population was examined.
X
ABCA3 p.Arg295Cys 19861431:76:25
status: NEW
Login to comment

79 None of these individuals had the R295C variant, indicating that this variation is indeed a mutation and not a polymorphism.
X
ABCA3 p.Arg295Cys 19861431:79:34
status: NEW
Login to comment

82 The R295C mutation is located in the first ICL (ICL-1) of the protein (Fig. 2A) and is adjacent to the previously reported mutant E292V (2).
X
ABCA3 p.Arg295Cys 19861431:82:4
status: NEW
Login to comment

83 The R295C mutation resides in a region that is conserved in different members of the ABCA subfamily (Fig. 2B) and across ABCA3 homologs in vertebrates (Fig. 2C).
X
ABCA3 p.Arg295Cys 19861431:83:4
status: NEW
Login to comment

85 To examine whether the intracellular localization of the R295C mutant was altered, the glycosylation state of the R295C mutant was characterized.
X
ABCA3 p.Arg295Cys 19861431:85:57
status: NEW
X
ABCA3 p.Arg295Cys 19861431:85:114
status: NEW
Login to comment

92 ᜡ, Mutations reported previously; ɏd;, novel mutant R295C.
X
ABCA3 p.Arg295Cys 19861431:92:62
status: NEW
Login to comment

96 C: alignment of sequences surrounding the R295C mutation in human, rat, mouse, and chimpanzee.
X
ABCA3 p.Arg295Cys 19861431:96:42
status: NEW
Login to comment

102 To determine whether the R295C mutation affected the ATP hydrolysis activity of the R295C mutant, vanadate-induced nucleotide trapping with photoaffinity labeling of the trapped intermediate (3) was examined.
X
ABCA3 p.Arg295Cys 19861431:102:25
status: NEW
X
ABCA3 p.Arg295Cys 19861431:102:84
status: NEW
Login to comment

108 These results indicate that the ability of the R295C mutant to hydrolyze ATP is severely impaired.
X
ABCA3 p.Arg295Cys 19861431:108:47
status: NEW
Login to comment

122 A: 20 òe;g of membrane fraction from HEK293 cells transiently transfected with WT ABCA3-GFP (lanes 2 and 3) or with ABCA3-GFP mutants L101P (lanes 4 and 5), R295C (lanes 6 and 7), N568D (lanes 8 and 9), and L982P (lanes 10 and 11) were treated without (afa;) or with (af9;) endoglycosidase H (Endo H) and analyzed by 5% SDS-PAGE followed by immunoblotting with anti-GFP antibody. Lane 1, immunoblotting of untransfected HEK293 cells.
X
ABCA3 p.Arg295Cys 19861431:122:161
status: NEW
Login to comment

123 B: WT ABCA3-GFP (lanes 2 and 3) or ABCA3-GFP mutants L101P (lanes 4 and 5), R295C (lanes 6 and 7), N568D (lanes 8 and 9), and L982P (lanes 10 and 11) were treated without (afa;) or with (af9;) peptide N-glycosidase F (PNGase F) and were then analyzed by 5% SDS-PAGE followed by immunoblotting with anti-GFP antibody. Lane 1, immunoblotting of untransfected HEK293 cells.
X
ABCA3 p.Arg295Cys 19861431:123:76
status: NEW
Login to comment

130 Normal glycosylation and intracellular localization of the R295C mutant is indicated by the similar levels of sensitivity to Endo H and PNGase F observed for the wild-type ABCA3-GFP protein and the R295C mutant.
X
ABCA3 p.Arg295Cys 19861431:130:59
status: NEW
X
ABCA3 p.Arg295Cys 19861431:130:198
status: NEW
Login to comment

140 One possibility is that an interaction between the R295C mutation and the patient`s prematurity resulted in the severe BPD observed.
X
ABCA3 p.Arg295Cys 19861431:140:51
status: NEW
Login to comment

143 In conclusion, clinical management of a premature infant with severe BPD and chronic respiratory failure led to the discovery of the novel ABCA3 mutation R295C.
X
ABCA3 p.Arg295Cys 19861431:143:154
status: NEW
Login to comment